| HGF-X7, VM-202, NL003 | |
| ViroMed Co., Ltd. | |
| I/II | |
| 17% (Same As Avg.) | |
| Non-Viral Gene Therapy | |
| Hepatocyte growth factor receptor (c-Met) | |
| Biologic | |
| Intramuscular (IM) |
Fiche créée le 26/11/2015 par 
Guillaume vue 7 fois.
| HGF-X7, VM-202, NL003 | |
| ViroMed Co., Ltd. | |
| I/II | |
| 17% (Same As Avg.) | |
| Non-Viral Gene Therapy | |
| Hepatocyte growth factor receptor (c-Met) | |
| Biologic | |
| Intramuscular (IM) |
Fiche créée le 26/11/2015 par Guillaume vue 7 fois.